Literature DB >> 11160149

Local and systemic control of the osteoblast.

G J Strewler1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11160149      PMCID: PMC199200          DOI: 10.1172/JCI11777

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  15 in total

Review 1.  Therapeutic approaches to bone diseases.

Authors:  G A Rodan; T J Martin
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

2.  The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure.

Authors:  M Parisien; S J Silverberg; E Shane; L de la Cruz; R Lindsay; J P Bilezikian; D W Dempster
Journal:  J Clin Endocrinol Metab       Date:  1990-04       Impact factor: 5.958

3.  Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone.

Authors:  L M Calvi; N A Sims; J L Hunzelman; M C Knight; A Giovannetti; J M Saxton; H M Kronenberg; R Baron; E Schipani
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells.

Authors:  H Dobnig; R T Turner
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

5.  Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development.

Authors:  B Lanske; M Amling; L Neff; J Guiducci; R Baron; H M Kronenberg
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

6.  Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Authors:  P Ducy; M Amling; S Takeda; M Priemel; A F Schilling; F T Beil; J Shen; C Vinson; J M Rueger; G Karsenty
Journal:  Cell       Date:  2000-01-21       Impact factor: 41.582

7.  Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia.

Authors:  E Schipani; C B Langman; A M Parfitt; G S Jensen; S Kikuchi; S W Kooh; W G Cole; H Jüppner
Journal:  N Engl J Med       Date:  1996-09-05       Impact factor: 91.245

8.  Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.

Authors:  N E Lane; S Sanchez; G W Modin; H K Genant; E Pierini; C D Arnaud
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

9.  Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development.

Authors:  N Amizuka; A C Karaplis; J E Henderson; H Warshawsky; M L Lipman; Y Matsuki; S Ejiri; M Tanaka; N Izumi; H Ozawa; D Goltzman
Journal:  Dev Biol       Date:  1996-04-10       Impact factor: 3.582

10.  Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells.

Authors:  P Bianco; S A Kuznetsov; M Riminucci; L W Fisher; A M Spiegel; P G Robey
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.